SCHEMBL31106310

SCHEMBL31106310

CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1CN2c1ccc(N)nc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 2/20 0.53
▸ GPR119 Q8TDV5 2/20 0.52
▸ HSD11B1 P28845 1/20 0.47
▸ PARP1 P09874 1/20 0.46
▸ CHRNB2 P17787 1/20 0.44
▸ CHRNA4 P43681 1/20 0.44
▸ RET P07949 2/20 0.42
▸ F13A1 P00488 1/20 0.42
▸ TGM2 P21980 1/20 0.42
▸ TGM1 P22735 1/20 0.42
▸ IDH1 O75874 1/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ BCR P11274 1/20 0.40
▸ AR P10275 1/20 0.39
▸ MAPK8 P45983 1/20 0.39
▸ SPR P35270 1/20 0.38
▸ SRC P12931 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12425412 1.00 HDAC1 (0.53) HDAC1GPR119HSD11B1PARP1CHRNB2
SCHEMBL15249213 1.00 HDAC1 (0.53) HDAC1GPR119HSD11B1PARP1CHRNB2
SCHEMBL30316252 1.00 HDAC1 (0.53) HDAC1GPR119HSD11B1PARP1CHRNB2
SCHEMBL29437386 1.00 HDAC1 (0.53) HDAC1GPR119HSD11B1PARP1CHRNB2
SCHEMBL22387840 1.00 HDAC1 (0.53) HDAC1GPR119HSD11B1PARP1CHRNB2
SCHEMBL18573301 1.00 HDAC1 (0.53) HDAC1GPR119HSD11B1PARP1CHRNB2
SCHEMBL2301999 0.90 GPR119 (0.47) HDAC1GPR119HSD11B1PARP1CHRNB2
SCHEMBL15034386 0.87 GPR119 (0.53) HDAC1GPR119HSD11B1PARP1CHRNB2
SCHEMBL31459152 0.85 GPR119 (0.52) HDAC1GPR119HSD11B1PARP1CHRNB2
SCHEMBL30248832 0.85 GPR119 (0.52) HDAC1GPR119HSD11B1PARP1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111333627-B Substituted 2-hydro-pyrazole derivatives as anticancer agents 正大天晴药业集团股份有限公司 2024-09-13 — — CN disclosed
Send feedback